Saltar al contenido principal

 

You may feel the traditional approach to type 2 diabetes is incomplete.

 

 

Financially, type 2 diabetes has many
self-insured employers worried and concerned.

Using UHC data, we can see the concern.

 

*November 2024 internal analysis of all UnitedHealthcare members (commercial, M&R, CNS, UMR), aged 20-64, continuously enrolled in 2022 and 2023. PMPY costs included Medical + Rx costs.

 

Level2 offers improvement beyond management with The Level2 Assured Value Program.

A clinical model focused on improvement

Level2 offers clinical care beyond traditional management, helping members with lowering glucose to improve type 2.

  • Members start with a continuous glucose monitor (CGM) to see glucose in new ways, included in the program fee
  • CGM data informs provider-led care teams of physicians, nurses, dietitians, and coaches who offer 1:1 guidance
  • Members can work to form new habits, improve glucose and make meaningful change

 

Assures employer value

Level2 clinical model works to change the cost trend of those living with type 2 by helping them improve and feel better.

  • Value is generated with 100% of program fees reconciled against clinical outcomes and actual medical & Rx claims. (Membership requirements apply. Contact the Level2 Sales Team for details.)
  • Offers employers flexibility with ability to be added to most plans.
“La tecnología líder y el apoyo clínico especializado que ofrece Level2 son realmente beneficiosos tanto para la salud de nuestros empleados con diabetes tipo 2 como para los posibles ahorros de costos a largo plazo para nuestra organización”.

Loren Kennedy

Vicepresidente sénior de Recursos humanos en World Travel Holdings, una empresa de viajes global que adoptó Level2.

Ready to see what the Level2 Assured Value Program can mean for you?

 

Contáctanos

1Sam Bacon, Nels Thompson, David Ferrell, Jason Fung; 943-P: Improved Glycemic Outcomes after One Year Among Level2 Members. Diabetes, 20 de junio de 2023; 72 (Supplement_1): 943–P. https://doi.org/10.2337/db23-943-P

Powered by Translations.com GlobalLink Web Software